Latest News

12345678910
Atlassian: 3 Key Takeaways for Long-Term Investorsfool.com
Forward-deployed engineers, not professional services staff, build the custom integrations driving AI adoption without diluting margins.
Via The Motley Fool · November 7, 2026
The Artificial Intelligence (AI) Boom Is Far From Over. Here Are 4 Potential Long-Term Winnersfool.com
The bullish case for these companies continues to get stronger.
Via The Motley Fool · November 7, 2026
Arista Networks vs. Okta: Which Technology Stock Is a Better Buy for 2027?fool.com
Arista's data center dominance meets Okta's identity security in a head-to-head matchup, with a sharp valuation gap that could sway a 2027 portfolio.
Via The Motley Fool · November 7, 2026
AI Stocks Are Falling; Bitcoin Is Holding Ground. Here's What Could Come Next.fool.com
Bitcoin's relative stability amid market turbulence portends well for its future.
Via The Motley Fool · November 7, 2026
These 5 Consumer Stocks Raised Their Dividends in 2026. Here's What $10,000 in Each Pays in 2027.fool.com
Past performance may not guarantee future results. But, it certainly does suggest what likely awaits.
Via The Motley Fool · November 7, 2026
2 Soaring Stocks to Hold for the Next 20 Yearsfool.com
One's a 103-year-old toy maker. The other's a cruise line that caters to a cultured crowd. Both are near the end of a banner year, and the next two decades look even better.
Via The Motley Fool · November 7, 2026
Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investorsfool.com
IHE offers lower costs and higher income through a concentrated play on established drugmakers, while IBB provides broader exposure to 243 biotech firms with higher volatility.
Via The Motley Fool · November 7, 2026
Prediction: Here's What a $1,000 Investment in Rivian Will Be Worth by 2030 if the R2 Ramp Holdsfool.com
Rivian's R2 is now its best-selling vehicle, which could put the company one step closer to profitability.
Via The Motley Fool · November 7, 2026
Prediction: These Are the 3 Biggest Threats Facing SpaceX in 2027fool.com
Elon Musk may have scored another own goal.
Via The Motley Fool · November 7, 2026
Axon Enterprise vs. Figma: Do Tasers or Cloud Services Make for a Better Stock Buy for 2027?fool.com
Axon's revenue surged past $2.8 billion in 2025, but Figma's larger free cash flow tells a very different story about which growth model holds up.
Via The Motley Fool · November 7, 2026
Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investorsfool.com
Canopy's EU GMP certification spans its entire supply chain, so it can sell into Europe without relying on third parties.
Via The Motley Fool · November 7, 2026
1 AI Stock I'll Buy Hand Over Fist If the Market Crashesfool.com
Most investors haven't realized how much this company is exposed to artificial intelligence.
Via The Motley Fool · November 7, 2026
NA Construction (NOA) Q3 2026 Earnings Call Transcriptfool.com
Acquisition lifted revenue, but a Fargo loss weighed on quarterly earnings.
Via The Motley Fool · November 7, 2026
What Koppers (KOP) Said on Its Q3 Earnings Callmarketbeat.com
Koppers (NYSE:KOP) lowered its 2026 earnings outlook after rising raw material and freight costs outpaced the company’s ability to recover them through pricing, even as third-quarter sales grew and year-to-date cash flow reached a record. The company reported third-quarter sales of $499 million, up
Via MarketBeat · November 7, 2026
Kardigan Extends Phase 2 Ataciguat Trial Assessment, Targets 2027 Resultsmarketbeat.com
Kardigan (NASDAQ:KARD) said its phase 2 trial of investigational drug ataciguat in aortic stenosis is fully enrolled and that it will assess the study’s primary endpoint at 48 weeks, rather than 24 weeks. Top-line results are expected in the second half of 2027. The KATALYST-AV trial’s primary endp
Via MarketBeat · November 7, 2026
What Kennametal (KMT) Said on Its Q1 Earnings Callmarketbeat.com
Kennametal (NYSE:KMT) reported a sharp increase in earnings and sales for the first quarter of fiscal 2027, but the industrial tooling company said higher tungsten costs drove a substantial cash outflow and weighed on volumes in its Infrastructure business. Sales rose 54% both organically and on a
Via MarketBeat · November 7, 2026
McKesson Q2 Earnings Call Highlightsmarketbeat.com
McKesson (NYSE:MCK) raised its fiscal 2027 adjusted earnings outlook after reporting higher second-quarter revenue and profit, supported by prescription volumes, specialty distribution and demand for medication access services. The company now expects adjusted earnings of $45.60 to $46.40 per dilut
Via MarketBeat · November 7, 2026
What Kinetik (KNTK) Said on Its Q3 Earnings Callmarketbeat.com
Kinetik (NYSE:KNTK) expects full-year 2026 adjusted earnings before interest, taxes, depreciation and amortization to land at the high end of its guidance range after record processed gas volumes and stronger-than-expected third-quarter results. The midstream company reported third-quarter adjusted
Via MarketBeat · November 7, 2026
Kayne Anderson BDC Q3 Earnings Call Highlightsmarketbeat.com
Kayne Anderson BDC (NYSE:KBDC) reported higher third-quarter investment income and maintained its quarterly dividend, even as credit problems in several portfolio companies weighed on net asset value and pushed non-accruals higher. The business development company generated net investment income of
Via MarketBeat · November 7, 2026
What Kyndryl (KD) Said on Its Q2 Earnings Callmarketbeat.com
Kyndryl (NYSE:KD) reaffirmed its fiscal 2027 outlook after reporting higher margins and growth in its consulting business for the second quarter, even as total revenue declined from a year earlier. The technology infrastructure services company reported revenue of $3.65 billion for the quarter ende
Via MarketBeat · November 7, 2026
Joby Aviation Q3 Earnings Call Highlightsmarketbeat.com
Joby Aviation (NYSE:JOBY) raised its 2026 revenue guidance after a record third quarter for its Blade passenger business, while executives outlined plans to advance electric air taxi certification and pursue early commercial flights in 2027. The company reported third-quarter revenue of $55 million
Via MarketBeat · November 7, 2026
Jackson Financial Q3 Earnings Call Highlightsmarketbeat.com
Jackson Financial (NYSE:JXN) reported third-quarter 2026 adjusted operating earnings of $7.55 per diluted share, as growth in spread-based income and record annuity sales supported results. The company also reaffirmed its full-year capital generation and shareholder return targets. Chief Executive
Via MarketBeat · November 7, 2026
Kadant Q3 Earnings Call Highlightsmarketbeat.com
Kadant (NYSE:KAI) reported record third-quarter revenue and adjusted earnings as aftermarket parts sales and acquisitions helped offset a slower market for large capital equipment projects. The company also raised its full-year adjusted earnings outlook. Revenue increased 15% from a year earlier to
Via MarketBeat · November 7, 2026
5 Stocks Yielding 5X the Nasdaq-100 to Buy in Novemberfool.com
The Nasdaq-100 pays about 0.6%. These five consumer stocks pay 5 times that, and one of them just closed the deal that makes it the owner of Tylenol.
Via The Motley Fool · November 7, 2026
Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?marketbeat.com
Dutch Bros beat Q3 EPS and revenue estimates, but shares fell 21% as slowing customer traffic growth raised concerns about the sustainability of its aggressive store expansion plans.
Via MarketBeat · November 7, 2026
Docusign vs. Monday.com: Absolute Scale vs. Faster Growth in Tech Revenuesfool.com
Docusign holds a commanding revenue lead, but Monday.com's steeper growth rate is steadily narrowing the gap.
Via The Motley Fool · November 7, 2026
Warren Buffett's Berkshire Compounded at More Than 19% a Year Over Six Decades, Nearly Double the S&P 500's 10% Return. Can Investors Still Apply That Playbook Today?fool.com
If you'd invested $5,000 in Berkshire stock 60 years ago, you would be sitting on a massive fortune today.
Via The Motley Fool · November 7, 2026
Anthropic's IPO Could Come Within Weeks. Amazon Already Owns a Piece of It.fool.com
The e-commerce giant already carries its stake at around $239 billion. What changes when the Claude maker's stock trades?
Via The Motley Fool · November 7, 2026
Decoding Healthcare ETFs: Different Sectors, Different Strategiesfool.com
RSPH offers broader sector diversification with lower volatility, while XBI delivers higher short-term gains but with steeper drawdowns.
Via The Motley Fool · November 7, 2026
SCHD Just Hit a Record High Following Midterm Election Results. I'd Still Rather Buy This Dividend King for Passive Income.fool.com
Investors are pouring into dividend-paying stocks and ETFs as Democrats gain control of Congress.
Via The Motley Fool · November 7, 2026
Datadog vs. Docusign: Which Technology Stock Is a Better Buy for 2027?fool.com
Datadog's revenue is growing roughly three times faster than Docusign's, but the valuation gap between them is just as striking.
Via The Motley Fool · November 7, 2026
AMD Stock Popped After Earnings, Then Gave It All Back. Is It a Buy Now?fool.com
AMD's results were good, but the overall picture of the stock isn't as great.
Via The Motley Fool · November 7, 2026
Here's the Average Social Security Benefit at Age 62fool.com
Claiming at 62 means accepting a permanent reduction in monthly income, but it unlocks years of immediate cash flow.
Via The Motley Fool · November 7, 2026
Why Marvell Technology Stock Plunged 28.1% This Weekfool.com
Investors don't see Marvell's new acquisition as being so marvelous.
Via The Motley Fool · November 7, 2026
Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?marketbeat.com
Astera Labs posted Q3 revenue up 153.6% and strong EPS growth, beating estimates, while analysts trimmed price targets but kept bullish ratings amid the stock's recent pullback.
Via MarketBeat · November 7, 2026
What James Hardie Industries (JHX) Said on Its Q2 Earnings Callmarketbeat.com
James Hardie Industries (NYSE:JHX) reported higher sales and earnings for its fiscal second quarter and raised its free cash flow target, even as management lowered its outlook for the housing market. Net sales from continuing operations rose 24% from a year earlier to $1.43 billion. Adjusted EBITD
Via MarketBeat · November 7, 2026
McDonald's Q3 Earnings Call Highlightsmarketbeat.com
McDonald's (NYSE:MCD) said U.S. comparable sales turned positive in September after declines earlier in the third quarter, as the company restored digital promotions and shifted marketing toward established value offerings. The chain is now testing additional low-priced bundles ahead of a planned na
Via MarketBeat · November 7, 2026
MBIA Q3 Earnings Call Highlightsmarketbeat.com
MBIA (NYSE:MBI) reported a wider third-quarter net loss as a smaller benefit from insurance loss reserves weighed on results, while executives said resolving the company’s exposure to Puerto Rico’s electric utility remains their operational priority. The financial guarantor posted a consolidated ne
Via MarketBeat · November 7, 2026
What JELD-WEN (JELD) Said on Its Q3 Earnings Callmarketbeat.com
JELD-WEN (NYSE:JELD) reported higher adjusted earnings for the third quarter of 2026, helped by tariff refunds and cost savings, while warning that demand for windows and doors was weaker than expected. The company maintained its full-year revenue and adjusted EBITDA guidance despite lowering its m
Via MarketBeat · November 7, 2026
Nextdoor Q3 Earnings Call Highlightsmarketbeat.com
Nextdoor (NYSE:NXDR) reported third-quarter revenue and adjusted earnings above its guidance as weekly active users grew for a third consecutive quarter, helped by product changes and the return of previously inactive users. Revenue rose 14% year over year to $78.8 million, exceeding the company’s
Via MarketBeat · November 7, 2026
What Moelis & Company (MC) Said on Its Q3 Earnings Callmarketbeat.com
Moelis & Company (NYSE:MC) reported third-quarter 2026 revenue of $426 million, up 13% from a year earlier, as growth in mergers and acquisitions and capital structure advisory offset a softer quarter in capital markets. Revenue for the first nine months rose 10% to a record $1.15 billion, CEO
Via MarketBeat · November 7, 2026
What Mativ (MATV) Said on Its Q3 Earnings Callmarketbeat.com
Mativ (NYSE:MATV) reported lower third-quarter sales and adjusted earnings after a tornado disrupted its paper and packaging distribution network, offsetting growth in its advanced materials business. Executives said they expect sales volumes to grow in both operating segments in the fourth quarter,
Via MarketBeat · November 7, 2026
MasterBrand Q3 Earnings Call Highlightsmarketbeat.com
MasterBrand (NYSE:MBC) expects weaker cabinet demand and rising costs to pressure fourth-quarter earnings, as the company integrates its merger with American Woodmark and pushes back its debt-reduction target by a year. The cabinet maker reported third-quarter net sales of $1.04 billion in its firs
Via MarketBeat · November 7, 2026
What Main Street Capital (MAIN) Said on Its Q3 Earnings Callmarketbeat.com
Main Street Capital (NYSE:MAIN) reported a record net asset value per share for the third quarter of 2026, as appreciation in its investment portfolio helped offset slower investment activity and lower distributable income compared with earlier periods. The company’s net asset value rose to $34.22
Via MarketBeat · November 7, 2026
Madison Air Solutions Q3 Earnings Call Highlightsmarketbeat.com
Madison Air Solutions (NYSE:MAIR) raised its full-year outlook after third-quarter sales rose 25%, with demand for data center cooling and other commercial products contributing to a record backlog. The company reported net sales of $1.127 billion and adjusted EBITDA of approximately $299 million,
Via MarketBeat · November 7, 2026
Here's How These 6 Big Bank Stocks Make Their Moneyfool.com
From card fees and wealth management to equities trading, here's where each of the six biggest banks made its money last quarter.
Via The Motley Fool · November 7, 2026
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?fool.com
Bristol Myers trades at under 10 times forward earnings, while Vertex commands nearly triple that multiple, but its margins are roughly double.
Via The Motley Fool · November 7, 2026
3 Artificial Intelligence (AI) Stocks I’d Buy Without Hesitation in a Market Crashfool.com
These companies have promising prospects. They would be even more attractive on the dip.
Via The Motley Fool · November 7, 2026
Not Nvidia. Not Micron. After the Chip Sell-Off, I'd Buy This AI Stock and Hold It Forever.fool.com
The market is shifting away from chip stocks, but that could create some great opportunities for investors.
Via The Motley Fool · November 7, 2026
The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?fool.com
PJP delivered 32.8% returns over one year with concentrated U.S. pharma exposure, while IXJ offers broader global healthcare diversification and a higher dividend yield.
Via The Motley Fool · November 7, 2026